Examining Hepatitis C Virus Treatment Access
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Last Updated on May 13, 2020 by HepFree NYC
Related Articles
-
Job | Leading With Lived Experience Consultants @HepNET
Leading With Lived Experience (LLE) Consulting Cohort @HepNET (Apply by: Wednesday, August 31) NASTAD and its partners National Viral Hepatitis Roundtable (NVHR) and National Association of County and City Health Officials (NACCHO) are working with state and local health departme...
-
USPSTF Recommends Hep B Screening in High Risk Individuals
The updated recommendation comes after growing evidence on the effectiveness of antiviral treatments, and is in line with recommendations from the CDC and the American Association for the Study of Liver Diseases. The USPSTF has a separate Grade A Recommendation on screening fo...
-
Bronx Premiere of “The Fix” Documentary
The Albert Einstein College of Medicine Division of Substance of Abuse invites you to the Bronx Premiere of “The Fix”!
-
FDA Approves Revisions to the Olysio (Simeprevir) Label, Including Dosing Recommendations
DA approved revisions to the Olysio (simeprevir) label to include dosing recommendations for the treatment of HCV/HIV-1 coinfection and to expand the indications and usage to include genotype 4 infection.
-
Clinical Preceptorship in Hep C and HIV Treatment (AETC)
This CME activity is intended to lead to improved patient care and safety based upon an assessment of gaps in knowledge, competence and performance.
-
Press Release | 2016 World Hepatitis Day (Hep Free NYC)
World Hepatitis Day provides a platform for people to speak out, be engaged and take action to ensure global commitments are met and viral hepatitis is eliminated by 2030.
-
Comment! Hep C Screening Recommendations (USPSTF)
The USPSTF gives a “B” rating for testing hepatitis C among injection drug users and others at high risk, a major improvement over previous guidelines However, the Task Force failed to match the Centers for Disease Control and Prevention’s lifesaving recommendation of testi...
-
NYS ADAP Includes New Hep C Meds on Formulary
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
